Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4846312
Max Phase: Preclinical
Molecular Formula: C42H61NO4S
Molecular Weight: 676.02
Molecule Type: Unknown
Associated Items:
ID: ALA4846312
Max Phase: Preclinical
Molecular Formula: C42H61NO4S
Molecular Weight: 676.02
Molecule Type: Unknown
Associated Items:
Canonical SMILES: C=C(C)[C@@H]1CC[C@]2(COC(=O)c3ccccc3C(=O)N3CCSCC3)CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12
Standard InChI: InChI=1S/C42H61NO4S/c1-27(2)28-14-19-42(26-47-37(46)30-11-9-8-10-29(30)36(45)43-22-24-48-25-23-43)21-20-40(6)31(35(28)42)12-13-33-39(5)17-16-34(44)38(3,4)32(39)15-18-41(33,40)7/h8-11,28,31-35,44H,1,12-26H2,2-7H3/t28-,31+,32-,33+,34-,35+,39-,40+,41+,42+/m0/s1
Standard InChI Key: AYOFQVJJFMYFBK-RLIXTTMDSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 676.02 | Molecular Weight (Monoisotopic): 675.4321 | AlogP: 9.05 | #Rotatable Bonds: 5 |
Polar Surface Area: 66.84 | Molecular Species: NEUTRAL | HBA: 5 | HBD: 1 |
#RO5 Violations: 2 | HBA (Lipinski): 5 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 2 |
CX Acidic pKa: | CX Basic pKa: | CX LogP: 8.32 | CX LogD: 8.32 |
Aromatic Rings: 1 | Heavy Atoms: 48 | QED Weighted: 0.25 | Np Likeness Score: 1.66 |
1. Pęcak P, Orzechowska B, Chrobak E, Boryczka S.. (2021) Novel betulin dicarboxylic acid ester derivatives as potent antiviral agents: Design, synthesis, biological evaluation, structure-activity relationship and in-silico study., 225 [PMID:34425312] [10.1016/j.ejmech.2021.113738] |
Source(1):